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Abstract.  The EGF receptor (EGFR) upon activation 
signals increased cell movement. However, the do- 
mains within the receptor, and the pathway which trig- 
ger movement are undefined. We expressed EGFR 
mutants at physiologic levels in receptor-devoid NR6 
cells to investigate this biologic response. The recep- 
tors possessed kinase activity and underwent auto- 
phosphorylation as predicted by primary amino acid 
sequence. EGF-induced cell motility was assessed in 
vitro by excess migration into an acellular area and 
colony scatter in the presence of saturating concentra- 
tions of EGF. 
Wild-type (WT)-EGFR signaled increased motility. 
However, replacing the conserved lysine  TM  with methi- 
onine resulted in a kinase-inactive receptor which did 
not elicit movement. Removal of the entire terminus 
by truncation (c973) also abrogated ligand-induced 
motility. Thus, we concentrated on the carboxy- 
terminal domains. EGF-induced movement was seen 
with a less-truncated mutant (c'1000)  that contained a 
single autophosphorylated tyrosine (tyrosine~). Other 
mutants, c991  and c'1000F 992, in which this tyrosine 
was removed did not signal motility. Fusion mutants 
which presented other autophosphorylated tyrosine do- 
mains also exhibited EGF-induced movement. These 
findings suggested that the presence of both an au- 
tophosphorylated tyrosine signaling domain and the 
kinase activity are necessary for this biologic re- 
sponse. 
All kinase-positive mutants signaled cell prolifera- 
tion but only those that contained autophosphorylat- 
able tyrosines induced movement. The motility re- 
sponses mediated by these EGFR were identical in the 
pi'esence or absence of mitomycin-C, at a dose (0.5 
/~g/ml) which completely inhibited cell proliferation. 
On the other side, D-actinomycin (50 ng/ml) blocked 
EGF-induced motility but did not affect thymidine in- 
corporation. Thus, EGF-induced mitogenesis and cell 
motility are mediated through different pathways. 
TIVATION of the epidermal growth factor receptor 
(EGFR) ~  signals many cellular biological responses 
ranging from mitogenesis to induction of  differentia- 
tion (6, 9, 31, 49).  The mitogenic activity of EGFR and its 
transduction as the oncogene v-erbB initially evoked interest 
in its roles in cell proliferation and tumor growth. Increased 
signaling by either overexpression of wild-type EGFR (17) 
or expression  of down-regulation-defective  receptors (32, 
51)  results  in  cell  transformation  and  tumor  formation. 
Numerous studies have associated increased levels of EGFR 
and amplification of its gene with progression of certain de 
novo  human  neoplasias  (19, 27,  36,  37,  55).  As  tumor 
progression requires cell phenotypes other than simply dys- 
regulated proliferation,  such as invasiveness and motility, it 
has been speculated that EGFR-stimulated  responses other 
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1. Abbreviations used in this paper: EGFR, epidermal growth factor recep- 
tor; WT, wild-type. 
than mitogenesis  may be involved.  EGFR activation  has 
been shown to elicit cell migration and increased random 
movement (1, 4, 53). Ligand-stimulation leads to production 
of extracellular matrix degrading proteases and extracellular 
matrix constituents (33, 34, 46, 54). The EGFR's role in ma~ 
trix remodeling and cell migration has widespread implica~ 
tions in organogenesis and tumor invasion and metastasis. 
Recent investigations of receptors with intrinsic tyrosine 
kinase activity have uncovered amino acid motifs crucial for 
specific signaling pathways and interactions with secondafyl 
effector molecules. Much of the non-kinase intracellularfd~ I 
gion has been deleted in the EGFR with retention of~tlie. 
mitogenic response (16, 51). The EGFR's long carboxyl- 
terminus has been shown to regulate kinase activity (3,  13, 
48), and to include at least five tyrosines which can be au- 
tophosphorylated  upon  ligand  stimulation.  These  phos, 
photyrosines can associate with the src homology-2 (St-I2)~ 
domains  found  in  numerous  second  messengers  (e.g., 
PLC-3,, GAP, PI-3 kinase) (8, 28, 30, 42), and through,these 
interactions  initiate signaling. 
At least two of these signaling pathways can be..Jinked~to 
cell movement. PLC-3,, which associates preferentially with 
© The Rockefeller University Press,  0021-9525/94/02/547/9  $2.00 
The Journal of Cell Biology, Volume 124, Number 4, February 1994 547-555  547 y992 on EGFR (10, 42), has been implicated in the pathway 
responsible for the reorganization of the cytoskeleton. PLC,y 
hydrolyzes PIP2 which leads to the release of profilin, a cy- 
toplasmic actin-binding protein (22).  Alternatively,  EGFR 
activation leads to membrane ruffling and reorganization of 
focal adhesions  through  activation of members of the rho 
subfamily of GTP-binding  proteins  (40,  41).  These events 
may be responsible for mediating EGFR effects on cell motil- 
ity. However, it has not been shown that such interactions are 
required  to elicit this  response.  EGFR lacking  autophos- 
phorylated tyrosines are capable of activating protein kinase 
C  (52) and MAP kinase (15). 
In this study, we expressed genetically engineered EGFR 
mutants on the murine fibroblast cell line NR6, which lacks 
the endogenous EGF receptors. We investigated the ability 
of various EGFR to elicit cell motility. These truncation and 
point mutants isolated a single autophosphorylated tyrosine, 
y992. Further truncation/fusion mutants which isolated other 
autophosphorylation  sites were examined.  Ligand-induced 
receptor autophosphorylation  and tyrosine kinase  activity 
were determined to be required for the biological response 
of cellular motility.  Furthermore,  this ligand-induced  aug- 
mentation of cell motility was separable from mitogenesis. 
Materials and Methods 
Construction of  EGFR Mutants 
EGFR mutants were constructed by standard methods. The point mutant 
M  TM  was constructed by replacing K  TM with a methionine cudun (12) by 
site-directed mutagenesis (26). The mutants c973, c991, and all000 also 
were generated by site-directed mutagenesis in which stop codons were en- 
coded after the amino acid number indicated. The point mutant c'1000F 992 
was  created from c'1000  by  replacing yss2  with  a  phenylalanine codon 
(F992). The fusion mutants c'958f  ~8-9~, c'958f It'd-n54, and c958f  11~°-117a 
linked c'958 with fusion segments containing the domains around y992, 
yl1~, and yH73, respectively. This was accomplished by introducing a Sal 
I site (encodes -V-D-) distal to amino acid 958 by site-direeted mutagenesis 
and recreating the specified sequences by oligonucleotide linkers. Clones 
were verified by sequencing. Deduced amino acid sequences of the con- 
structs are shown in Fig.  1. 
Stable Expression of  EGFR in NR6 Cells 
The EGFR were expressed in NR6 cells, 3T3-derivatives which lack endog- 
enous receptors (39). This was accomplished by retrovirus-mediated trans- 
ductiun as previously described (50, 51). The constructs were cloned into 
the gag position of a  Moloney MLV-derived vector with an SV40 early 
promoter-driven neomycin-pbosphotransferase  gene in the env position, as 
the selectable marker. Plasmid DNA was introduced into an ecotropic pack- 
aging ceil line, ~b (29), using the lipofectin reagent (GIBCO/BRL, Gaithers- 
burg,  MD).  Packaged viruses were then used to infect the NR6 mouse 
fibroblast cells in the presence of 4  ~g/ml of polybrene in growth media 
(MEMtx supplemented with 7.5% FBS). 6 h later, these media were replaced 
with polybrene-free growth media. 36 h after infection, cells were selected 
in media containing 350/zg/mi G418 (GIBCO/BRL). Polyclonal lines con- 
sisting of more than 20 colonies were established and maintained in G418 
containing media (52). At least two separate infectant lines were generated 
and subsequently assayed for each construct. In all cases the independent 
lines presented near-identical EGFR characteristics and biologic responses, 
and are not distinguished in the results. 
Detection and Characterization of EGFR 
Presence of EGFR on the surface of infectant NR6 lines was determined 
by binding parameters and the ability of EGF to stimulate tyrosine kinase 
activity and cell proliferation. Scatchard analyses determined the apparent 
binding sites and affinity for EGF. Cells were grown to confluence in 6-well 
culture plates (,~250,000 cells/well), After incubating 30 rain in serum-free 
EGFR construct 
w'r 
c'1000 
c'1000F992 
c~)1 
c~73 
c~758  f988-996 
c~958f1146-1154 
c,958fl 170-1178 
Deduced amino acid seouence  a 
.. LVIQGDERMH  LPSPTDSNFY  RALMDEEDMD  DVVDADEYLI  PQQGFFSSPS.. 
., LVIQGDERMH  LPSPTDSNFY  RALMDEEDMD  DVVDADEYLI  PQQGFF* 
,. LVIQGDERMH  LPSPTDSNFY  RALMDEEDMD  DVVDADEFLI  PQQ(3FF* 
.. LVIQGDERMH  LPSFrDSNFY RALMDEEDMD  DVVDADE* 
., LVIQGDERMH  LPSPTDSNF* 
.. LVIQ VD  DADEYLIPQ* 
.  LVIQ VD  PDYQQDFFP* 
.. LVIQ VD  NAEYLRVAP* 
Figure I. Amino acid sequence of EGFR constructs. The sequences 
are deduced from sequencing of the cDNA clones. Sequences are 
shown from L 995.  * denotes a  stop codon. 
media, cells were incubated with 0.1 nM 12SI-labeled EGF and unlabeled 
EGF (0-100 nM) in binding buffer (DME with 25 mM Hepes, pH7.4, and 
0.2% BSA) at 4°C for 2 h. Unbound nSI-EGF was collected from the sn- 
pernatant and two washes with binding buffer. The cells were lysed and the 
bound 125I-EGF was collected. Free and bound lesI-EGF were counted and 
Bmax and Ko for each cell line were calculated from seatchard plots after 
subtracting background counts (radioactivity bound in presence of 10-100 
nM EGF). All constructs presented monophasic binding graphs. 
Kinase activity  was determined by  exposure of 90%  confluent cells 
(,~200,000  cells) to EGF (25  nM) for 5 rain at 37°C. Cells were lysed 
directly in SDS-PAGE (polyacrylamide gel electrophoresis) sample buffer 
under reducing conditions, and proteins size-separated through a 7.5 % gel. 
After transfer to a PVDF membrane, tyrosyl-cuntalning proteins were de- 
tected by an antibody which recognizes phosphotyrosine residues (PT03; 
Oncogene Sciences). Visualization was by a second antibody conjugated to 
alkaline pbosphatase followed by color development (ProtoBIot system; 
Promega). 
Autophosphorylatiun was determined  by immune-precipitation  of EGFR 
after EGF exposure. The cells were Iy'~l in lysis buffer (10% glycerol, 1% 
Triton X-100,  100 mM NaCl, 20 mM Hepes pHT.4,  and 1 mM Na Vana- 
date) and EGFR were immune-precipitated with an anti-EGFR monoclonal 
antibody against the extracellular domain (GRO1; Oncogene Sciences) fol- 
lowed by protein G-Sepharose 413. The precipitates were washed under 
stringent conditions (lysis buffer containing 500 mM NaC1 and 0.1% SDS). 
The immune-precipitates were fractionated through a 7.5 % polyacrylamide 
gel followed by transfer to a PVDF membrane. Anti-phosphotyrosine  anti- 
body  (V1D3;  Oncogene  Sciences)  detected  phosphotyrosyl-contalning 
EGFR. The blots were subsequently reprobed with an anti-EGFR antibody 
(LA22; UBI) to visualize non-phospborylated EGFR. 
EGFR-stimulated proliferation was determined by automated counting of 
cells after 4 d exposure to saturating concentrations of EGF (10 nM) (51). 
Briefly, 20,000 cells were plated in a 35-ram dish, let adhere in MEMc~ with 
7.5% serum, and then switched to MEMc~ supplemented with 1% dialyzed 
FBS (dFBS) for 48 h before testing. EGF was added and the cells counted 
4 d later. Numbers of cells were compared with and without added ligend. 
Cell Migration Assays 
EGFR-mediated motility was determined by two methods. In the first, cells 
were tested for the ability to move into a denuded area on a culture dish 
(5, 14). NR6 cells were plated on plastic and grown to confluence in MEMc~ 
with 7.5 % FBS. The cells were then switched  to 1% dFBS medium for 24 h. 
A rubber policeman introduced an acellular area at the center of the plate. 
The cells were then treated with or without EGF (25 nM) in parallel and 
incubated at 37°C. Photographs were taken at 0,  12, and 24 h. Cell migra- 
tion was determined by measuring the distance cells moved into the acellular 
area over time. This was done by measuring the distance between the two 
boundaries of cells on the photographs of same magnification. The mea- 
surements were taken by two individuals independently on a blinded basis 
to eliminate subjectivity; difference between the two sets of measurements 
were less than 5 %. Ligand-iuduced migration was compared to the non- 
'EGF treated (basal) migration and expressed as % of basal migration in 
each mutant EGFR expressing cell line at each time point. Mitogenesis- 
independent cell migration was determined in the presence of mitomycin-C 
(0.5  ~,g/ml). 
Colony scattering, as a second indicator of induced random cell move- 
ment, was adopted from studies of HSF/HGF (5, 21).  NR6 cell lines ex- 
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MEMct supplemented with 7.5%  FBS.  Upon compact colony formation 
(,x,200--400 ceils per colony), the ceils were switched to 1% dFBS medium 
for 24 h. The cells were then treated with or without EGF (25 nM) and in- 
cubated at 37*C. Photographs were taken on preselected colonies at 0,  12, 
and 24 h. The areas occupied by the same colony at these time points were 
measured from photographs. The measurements again were taken by two 
individuals on a blinded basis. Colony scatter was defined as the increase 
in colony area over time. EGF-induced colony scattering was expressed as 
% additional increase in colony area as compared to the non-EGF treated 
(basal) colony scattering. A  second series of experiments controlled for 
ligand-indueed mitogenesis by incorporation in the media of mitomycin-C 
(0.5 t~g/ml). 
pH]Thymidine Incorporation Assay 
Pharmacological effects of mitomycin-C and D-actinomycin on the EGF- 
induced mitogenic response were assessed by the ability of cells to incor- 
porate  [3Hlthymidine.  Cells  were  plated  on  plastic  and  grown  to 
confluence in MEMe~ with 7.5% FBS. The cells were then switched to 1% 
dFBS medium for 24 h. The ceils were subsequently treated with or without 
EGF (25 n_M) and incubated at 37°C for 16 h. [3H]thymidine (5/~Ci/ml) 
was added and incubation continued for another 10 h. The ceils were then 
washed with ice-cold PBS twice and incubated in 5% TCA at 4"C for 30 
rain. After two washes with PBS the cells were lysed in 0.2N NaOH and 
the  incorporated  [3H]thymidine  counted  by  scintillation  counter.  The 
effects of drug treatments were evaluated by [3H]thymidine incorporation 
assays in the presence or absence of mitomycin-C (0.5 ~g/ml) or D-actino- 
mycin (5 ~tg/ml or 50 ng/ml). 
Results 
Kinase Activity of the Receptor Is Required 
for EGF-induced  Motility 
Wild-type (WT) EGFR were expressed in the NR6 cells (51). 
A point mutation within the full-length EGFR replaced the 
ATP-complexing lysine at amino acid 721 with methionine 
(M  TM)  (25).  M  TM  did not demonstrate auto- or exo-kinase 
activity (Table I) (12). These cells were examined for motil- 
ity in response to EGF (Fig. 2). 
Cell movement was determined by two methods. In the 
first, an area ofa monolayer culture was denuded and the rel- 
ative distance traveled by the cells at the acellular front was 
determined 04, 45). The absolute migration of each cell line 
was determined either in the presence or absence of EGF 
(Fig. 2 A). To standardize our assays and account for slight 
day-to-day variation in the measurement of migration, we 
calculated the EGF-induced migration as a percent of basal 
motility observed in the non-EGF exposed cells tested in par- 
allel at each time point.  WT-EGFR NR6 ceils demonstrated 
enhanced migration in the presence of saturating concentra- 
tions of EGF (125 % increase) while M72~-EGFR expressing 
cells responded similarly to parental NR6 cells (Fig. 2 B). 
Increased cell movement also would be reflected in colony 
scattering (21), which can be quantified by the area described 
by the outlying cells of the colony. EGF-induced colony scat- 
tering was determined by increase in area occupied by in- 
dividual colonies in the presence of EGF and expressed as 
%  additional increase  in  area  as  compared  to  non-EGF 
treated colonies tested in parallel at each time point (Fig. 2 
C). Again, WT- but not M72~-EGFR expressing cells pre- 
sented enhanced motility in the presence of saturating level 
of ligand. This suggested that the kinase activity of  the recep- 
tor is required in the pathway that leads to the biological re- 
sponse of motility. 
1)rosine Autophosphorylation of  EGFR Constructs 
Expression of EGFR mutants on transformed B82 ceils (10, 
11)  revealed that the  tyrosine residue  at position 992  is 
the only one autophosphorylated proximal to the putative 
calpain  hinge  at  1037 (20).  Four  EGFR  (WT,  c'1000, 
c'1000F  992, and C ~91) which isolated this autophosphoryla- 
tion site were expressed on NR6 cells. The polyclonal infec- 
tant lines demonstrated homogeneous receptor distribution 
by immunostaining (data not shown) and presented EGFR 
with normal physiologic binding characteristics  (Table  I) 
(7). All four EGFR exhibited EGF-stimulated exo-kinase ac- 
tivity as determined by an increase in intensity and number 
of ceU proteins recognized by anti-phosphotyrosine antibod- 
ies (data not shown). Only the WT and c'1000 EGFR under- 
went ligand-induced autophosphorylation. Replacement of 
tyrosine by phenylalanine at position 992 eliminated auto- 
phosphorylation in the c'1000-truncated EGFR, though this, 
and the c'991-truncated  EGFR retained a tyrosine residue at 
position 974 (Fig.  1). 
Recent findings suggest that individual autophosphoryla- 
tion domains in the EGFR may substitute for each other in 
biologic functions and protein-protein interactions (42, 44). 
Table L Intrinsic Properties of EGFR Constructs Expressed in NR6 Cells 
Construct  Apparent Bm~*  Apparent Kd~  NR6 growth;  ~  PhosphotyrosylQ 
Parental  ndll  nail  100  na 
WT  100  0.4 nM  214 -t- 36  + + + 
M TM  50  0.3 nM  107  +  5  - 
c'1000  180  0.7 nM  308 5:78  + 
c'I000F  9'n  140  0.4 nM  352  +  41  - 
c'991  240  0.4 nM  278  +  79  - 
c'973  80  0.3 ILM  266 :t: 43  -- 
c958f  9u'9'~  120  0.2 nM  255  -I- 11  + 
c'958f  lv~-ll~  260  0.4 nM  260 +  64  + 
c'958t  alT°-nTs  35  0.1 nM  307  +  58  + 
* Properties of the major binding site as determined by "best-fit* calculation after subtracting non-specific binding (sites with dissociation constants, ~0.1 nM could 
not be detected); B.~ is  x 10  -3. 
Induced growth (as determined by cell counting) after 96 h in 10 n_M EGF vs no EGF, expressed as % of no EGF treatment; n  =  4-15. 
§ EGF-induced, as determined by anti-phosphotyrosyl antibody Western blot of immunopreeipitated EGFR. 
II rid, none detected; ha, not applicable. 
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Figure 2. EGF-induced cell motility  in NR6 cells expressing kinase 
active (WT) and inactive (M  72~) constructs.  (A) Migration into an 
acellular area was measured at different time pints from photo- 
graphs similar to the ones shown in Fig. 3. Absolute migration was 
determined by measuring the distance between the two boundaries 
of cells on the photograph.  Cells were exposed to EGF or diluent 
(non-EGF treated) and tested in parallel for each EGFR construct 
expressing  cell  line.  (B)  EGF-induced  cell  migration  into  the 
denuded area was calculated as the percentage of the basal (non- 
EGF treated) migration tested in parallel  at each time point.  (C) 
Colony scatter was determined similarly. EGF-induced colony scat- 
tering was assessed as the difference in percentage  increase over 
non-EGF-treated scattering at each time point. All assays were per- 
formed  in the presence  of mitomycin-C  (0.5 tLg/ml). Values are 
mean +  SEM; n > 4 for each cell line tested, p < 0.01 at 24 h be- 
tween WT +EGF and WT basal (no EGF treatment) or other cell 
lines; p > 0.5 for all other paired comparisons at 24 h. ~  - WT- 
expressing NR6 cells, --~ - M72|-expressing cells, and +  - paren- 
tal NR6 ceils. Open symbols in A denote cells tested in the absence 
of EGF, filled symbols are cells in the presence of EGE 
Therefore, fusion mutants were generated which linked the 
autophosphorylation domains surrounding the tyrosines at 
992,  1148, and 1173 to a minimal kinase-positive truncation 
mutant  (11) (c958~ s-9~,  c958t  ~l~t]~,  and  c958f  ~z7°-"78, 
respectively). These receptors demonstrated the predicted 
intrinsic properties, such as ligand-induced auto- and exo- 
kinase  activities  (Table  I).  A  non-autophosphorylatable 
truncation mutant (c'973) (11, 51) served as a control recep- 
tor being of approximately equal length (973 amino acids vs 
969 for the truncation/fusion EGFR). 
Autophosphorylation at ym Increases Ligand-induced 
Cell Movemen t 
The presence ofa tyrosine at position 992 enables the c'1000 
EGFR to activate PLC-7 (47), a secondary cffector molecule 
which has been linked to cytoskcletal reorganization (22). It 
was of interest to determine if EGFR phosphorylated at this 
tyrosine increased cell movement. In cell migration into an 
acellular area, significantly increased EGF-induced migra- 
tion (70 and  125 %,  respectively, over the untreated)  were 
observed  with  cells  expressing  the  autophosphoryla~ble 
constructs,  c'1000 and WT (Figs.  3  and 4  A).  No ligand- 
induced augmentation was seen with cells presenting c'991 
or  c'lO00F  992  EGFR.  The  NR6  cells  expressing  the  Y~ 
containing constructs, c'1000 and WT, also demonstrated 45 
and  60%  increases,  respectively,  in  EGF-induced  colony 
scattering as compared to the non-EGF-treated cells (Fig. 4 
B),  while  the  autophosphorylation-negative  mutant  cell 
lines failed to show any EGF effect. These data suggested 
that EGF-induced cell motility depended on the presence of 
an autophosphorylatable tyrosine. 
Cell Movement Is Induced by Other 
Autophosphorylation Positive Constructs 
The y992 autophosphorylation domain was fused to a mini- 
mal kinase-positive truncation mutant (d958P~-~).  In par- 
allel,  two other truncation/fusion EGFR were constructed 
representing two of the major in vivo autophosphorylation 
sites (c'958f  ~146-"54 and C1958f 1170-1178) (18).  These EGFR were 
used to determine if different autophosphorylation domains 
could substitute for each other in triggering the motility bio- 
logic response. These autophosphorylatable constructs dam- 
onstrated 70-130 % increases in cell migration into an acel- 
lular area and 40-80%  increases in colony scattering (Fig. 
5).  These responses were indistinguishable from those ex- 
hibited by cells expressing WT or ca00O EGFR. The mito- 
genic, non-autophosphorylated control EGFR, c973, failed 
to elicit augmented cell motility; these results were indistin- 
guishable  from those  derived  from the  c991,  c'1000F  992, 
and parental  cell lines.  With  all the  EGFR,  induced  cell 
movement segregated with the ability of the receptor to be 
autophosphorylated. 
High basal motility rates may either mask augmentation 
by EGF or already represent maximal movement. For the 
NR6  lines  which  failed to demonstrate EGF-induced  en- 
hanced motility, we examined the basal rates of cell move- 
ment to determine if these cells possessed anomalously high 
basal motility.  Basal colony scattering and cell migration 
rates did not differ between the positive and negative EGFR 
mutants (Table ID. Furthermore, the EGF-angmented rates 
of cells presenting the autophosphorylatable constructs ex- 
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tion  into  an  acellular  area. 
Confluent monolayers of NR6 
cells were denuded in the cen- 
ter. Cells were treated with or 
without 25 nM EGF for 24 h, 
and  photographs  were  taken 
at different  time points.  The 
dark lines on the left side of 
each photograph marked the 
plate to ensure that the same 
spot  was  photographed  and 
measured. This figure is a rep- 
resentative single experiment 
with all four cell lines tested 
simultaneously. 
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Figure 4.  EGF-induced motility in  NR6  cells expressing EGFR 
constructs which isolate y992. (A) Migration into an aceHular area 
and (B) colony scatter were determined as described in Materials 
and  Methods.  All  assays  were  performed  in  the  presence  of 
ceeded  those  of the  negative  EGFR.  These  findings  sug- 
gested  that the  observed  increased  movement must be as- 
cribed to specific signaling by the EGFR. 
Differences in receptor numbers and intrinsic characteris- 
tics may affect the extent of the biological responses noted. 
The  ligand-binding  affinities  of the  EGFR  fell closely  to- 
gether, being within the narrow range of experimental error 
(Table I). Numbers of receptors per cell (apparent B~)  did 
not correlate with the extent of either inducible or basal cell 
motility. Furthermore, two different infectant WT lines were 
compared.  These  expressed  different  numbers  of  EGFR 
(100,000 and 180,000 EGF-binding sites per cell). These cell 
lines behaved identically in the cell migration assay (176  + 
49 vs  161  5:63  at 12 h,  and 225  +  41  vs 229  5:22  at 24 
h). This suggests that the ligand-induced motility is indepen- 
dent of receptor number,  at least over the range expressed 
(Table I).  Alternatively,  diminished  ligand-induced  EGFR 
internalization  may enable some mutants  to  signal longer; 
this was not the case as all the EGFR displayed similar inter- 
nalization  rates  (k, 0.03-0.05  sec  -t  at 0.1  nM  EGF)  except 
for WT (0.10) and c973  (0.009).  Thus,  the ability to signal 
cell  motility  is  considered  to  be  intrinsic  to  the  various 
EGFR. 
Ligand-induced Cell Motility Is Independent of  and 
Separable from Ligand-induced Mitogenesis 
It was unlikely that the observed increases  in cell motility, 
noted by  12 h  of EGF exposure,  were secondary to EGF's 
mitomycin-C (0.5/zg/ml). Values are mean +  SEM; n > 6 for each 
cell  line tested.  ~  WT-expressing NR6  cells,  +  c'1000,  -o- 
c'991,  and +  c'1000F  ~.  p  <  0.01 between either WT or c'1000, 
NR6 cells and the non-autophosphorylatable constructs. 
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Figure 5. EGF-induced cell migration (A) and colony scattering (B) 
in NR6 cells expressing autophosphorylatable constructs. Relative 
rates of migration and increase in colony size were determined as 
described in Materials and Methods. All assays were performed in 
the presence ofmitomycin-C (0.5 gg/mi). Values are mean + SEM; 
n > 4 for each cell line tested. --~ WT-expressing NR6 cells, -~- 
C/958f  1170-1178  , -~- C/958f  1146-1154  , "O'- C~958f  988-996  , --[3"-  CX)73, and -~- 
parental NR6 ceils, p < 0.01 between any of the NR6 cells lines ex- 
pressing the autophosphorylatable constructs and parental or c'973- 
expressing cells. 
mitogenic  actions.  First,  all  kinase-positive  EGFR  stimu- 
lated mitogenesis  (Table I) but not migration.  Second,  the 
first wave of EGF-elicited DNA synthesis occurs only after 
17-21 h  in these cells and cell division after 24 h  (data not 
shown).  However, low background growth rates may be ac- 
Table IlL  Cell Motility in the Presence or Absence of 0.5 
gg/ml Mitomycin-C  Treatment 
Colony scatter*  Cell migrationS; 
Mitomycin-C:  - §  + II  -  ¶  +** 
Construct 
WT  65  +  26  59  +  23  211  225  +  41 
c'991  -16 5:1  -8  5:37  89  105  5:18 
c973  7  5:9  7  +  8  118  114 5:4 
c'lO00  31  5:5  45  5:18  nd** 
c'lO00F 992  8 5:5  -4  5:13  nd 
* Expressed as percentage increase over non-EGF treated colony scatter. 
Expressed as percentage of non-EGF treated migration. 
§n=3. 
II n  =  4--6. 
¶n=l. 
** n  =  4-12. 
~¢ rid, not done. 
celerated.  To ensure that the observed increases in ligand- 
induced cell motility was not due to EGF's mitogenic effect, 
ligand-induced mitogenesis of dispersed cells was monitored 
in  parallel  with  the  cell  motility  assays  to  determine  the 
correlation of the two events. We compared cell proliferation 
of the EGF-treated and -untreated cells, and the cell numbers 
after  24  h  were  within  20%  for  all  constructs  (not  sig- 
nificant).  Actual enumeration of cells in each colony of the 
colony scattering assays revealed a  <10%  discrepancy over 
the 24 h  experimental period. 
Motility  assays  were  performed  in  the  presence  of 0.5 
gg/ml of mitomycin-C to further ensure that EGF-induced 
mitogenesis did not interfere with our observations in cell 
motility. At this level of mitomycin-C, the low basal prolifer- 
ation rate was  further  reduced  and  EGF  exposure had no 
effect on cell number.  Cells expressing the various EGFR 
constructs migrated identically in the presence or absence of 
mitomycin-C (Table III). Thus, the EGF-induced movement 
was not secondary to the well-described mitogenic actions 
of this receptor system. 
Cell  motility  and  mitogenesis  are  separable  biological 
events.  Actinomycin  D  has  been  shown  to  preferentially 
block  cell  migration  at  concentrations  which  did  not  af- 
fect mitogenesis  (2,  23).  To further differentiate the EGF- 
induced cell migration response from mitogenesis, we treated 
NR6  cells  with  two  dosages  (50  ng/ml  and  5  gg/ml)  of 
D-actinomycin.  We assessed their effects on EGF-induced 
[3H]thymidine  incorporation  as  well  as  the  EGF-induced 
motility. EGF-induced [3H]thymidine incorporation was not 
Table II.  Basal and EGF-induced Cell Motility 
Cell migration*  Colony scatters 
Basal distance  EGF-induced  Basal rate  EGF-induced 
Autophosphorylation 
Positive constructs§  1.6  +  0.3  ** 
Negative constructs"  1.9  +  0.3  ¶ 
2.9  +  0.4  **  129  +  8  **  176  +  8 
2,0  +  0.4  155  +  7  I  148  +  14 
* Absolute cell migration after 24 h, in arbitrary  units. 
Percent of original colony area at time 0. 
§ Mean  -t- SEM of mean values of NR6 cells expressing WT, c'1000,  C195Sf  1170-117g, Ct958f  1144~-1154  ,  and  cl958f  98g-996 . 
U  Mean  +  SEM of mean values of parental NR6 cells and those expressing c'1000F  ~n, c991,  and c973. 
¶p > 0.3,  **p ~  0.01. 
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Cell Motility 
Cell migration* 
no D-actinomycint  50 ng/ml D-actinomycin§ 
Construct 
WT  225  +  41  II  117  :t:  13 
c'1000  170  +  11  I1  103  5:19 
c'1000F  ~  121  +  14  I  109  +  13 
c'991  105  +  18  I  103  +  33 
* EGF-induced migration after 24 h of 25 nM EGF treatment; expressed as 
percentage of non-EGF-treated cells, mean +  SEM. 
n  =  4-12. 
~n=3. 
lip  <  0.01;  ¶p  >  0,3;  there  were  no  statistically  significant differences 
between the various lines in the presence of D-actinomycin. 
blocked by low dose (50 ng/ml) D-actinomycin. In the pres- 
ence or absence of the drug at this low dose, EGF elicited 
the same sevenfold increase in [3H]thymidine incorporation 
over non-EGF-treated cells (n  =  3 cell lines: 7.5×  in the 
presence of D-actinomycin, 6.3×  in its absence), with no 
difference in  the  basal  incorporation  between  the  drug- 
treated and non-treated cells. However, high dose (5 #g/ml) 
D-actinomycin inhibited the basal and EGF-induced incor- 
porations. Treated cells showed only 1% incorporation of the 
non-drug-treated cells and did not respond to EGF exposure 
(n  =  3 cell lines). 
D-actinomycin, at either dose, blocked the EGF-induced 
cell migration and inhibited the basal level of movement (Ta- 
ble IV). Mitomycin-C spared this biological response. These 
findings indicate that the EGF-induced mitogenesis and cell 
motility have different sensitivity to DNA polymerase and 
RNA polymerase blockade and may require different levels 
of transcription.. 
Discussion 
EGF induces cell migration in certain receptor-bearing cells 
(1, 4, 53).  However,  the nature of this signal is undefined. 
Recent advances  suggest SH2-mediated associations may 
initiate signaling pathways leading to migration (22, 40, 41, 
47).  However,  other signals and biologic responses do not 
require intrinsic EGFR-mediated SI-I2 interactions (15, 52). 
To dissect the roles of autophosphorylation sites in the car- 
boxy terminus of EGFR in mediating the cellular biological 
response of cell motility, we have constructed mutants con- 
taining various autophosphorylation sites.  These mutants 
demonstrate the expected auto- and exo-kinase properties, 
even when the particular domains were relocated from distal 
sites and juxtaposed onto the end of the kinase domain. This 
suggests that the ability of a particular sequence in the EGFR 
to be autophosphorylated is dependent on the immediate 
context of the tyrosine residue. The biological responses that 
are modulated by autophosphorylation events also may be 
somewhat promiscuous. Thus, individual phosphotyrosines 
may substitute for each other in signaling interactions, as has 
been suggested for the situation involving EGFR Y~ and 
PLC-'y (42, 44). 
Herein, we demonstrated that EGF induces cell movement 
only through EGFR-containing phosphorylatable tyrosine 
residues. Initially this was noted with EGFR which isolated 
y992 by truncation of the receptor (c'1000). This receptor is 
fully capable of  mobilizing intracellular calcium (10) and ac- 
tivating PLC-'y (47).  c991  and c'1000F  ~  EGFR, both of 
which  contain a  non-phosphorylated tyrosine (y974), did 
not stimulate cell movement. To determine whether this cel- 
lular response is specific for the Y~ domain, fusion mu- 
tants were constructed to present other single autophosphor- 
ylation sites  (c'9581  ~x~"~  and  c'958f  ~lT°-ms) (18). These 
EGFR also augmented cell motility in a ligand-dependent 
manner.  The  results  further  support  the  contention that 
phosphotyrosine-mediated interactions may be  somewhat 
promiscuous, allowing similar SH2-binding motifs to substi- 
tute for each other (38, 42-44). In addition, the position of 
these autophosphorylatable tyrosines in relation to the ki- 
nase domain may not be critical in mediating the biological 
response of cell motility since the c'1000 mutant and the fu- 
sion  mutants  stimulated  cell  movement.  Designation  of 
immediate effector molecules which lead to the motility re- 
sponse may require point-mutational analyses in the back- 
ground of the wild-type receptor. 
These data do not demonstrate that the tyrosines must be 
phosphorylated for motility to be signaled. Replacement of 
a tyrosine by phenylalanine (e.g., yg~ > F992) not only pre- 
vents phosphorylation, but may interrupt tyrosine-mediated 
interactions.  Investigations have shown weak,  but signifi- 
cant, interactions between SH2 domains and unphosphor- 
ylated tyrosines (35).  However,  the presence of these SH2 
tyrosine motifs in a kinase-defective EGFR (M  TM) was not 
sufficient to mediate EGF-induced movement. As the EGFR 
requires kinase activity to trigger downstream biologic re- 
sponses (12, 24), it will be difficult to settle this point until 
the next link in this pathway is identified. 
Increased motility was independent of cell proliferation. 
All the constructs exhibited exo-kinase and elicited mitogen- 
esis in an EGF-dose dependent manner (Table I). NR6 cells 
expressing c973 EGFR are more sensitive to ligand-induced 
proliferation, cell transformation, and tumor promotion (32, 
51).  However,  these  cells,  and  others  which  presented 
non-phosphorylatable EGFR,  did  not demonstrate EGF- 
enhanced cell movement. In the cell lines which responded 
to EGF, movement was noted before the onset of DNA syn- 
thesis and cell division. Addition of mitomycin-C in concen- 
trations which prevented entry into S-phase, did not affect 
EGF-induced motility. Contrarily, low dose D-actinomycin 
inhibited EGF-induced cell motility but spared the ability to 
incorporate thymidine. In  sum,  certain EGFR constructs 
signaled mitogenesis without promoting movement, and an 
inhibitor of RNA synthesis blocked motility at concentra- 
tions which did not effect mitogenesis; and mitogenesis was 
prevented without affecting migration. Thus, EGF stimula- 
tion of cell migration was  separable  from the mitogenic 
signal. 
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